Aris Mining vs. Eldorado: Which Gold Mining Stock has Greater Upside?

Aris Mining (ARMN) reported Q3 2025 gold production of 73,236 oz (+25% sequential, +36.6% YoY) and 9M production of 186,651 oz, remaining on track for 2025 guidance of 230,000–275,000 oz; AISC rose to ~$1,641/oz and cash stood at $417.9M at quarter-end, while development assets (Soto Norte, Toroparu >6.5M oz resource) bolster its growth pipeline. Eldorado Gold (EGO) operates four mines and is advancing Skouries with first production expected Q1 2026 and projected 2026 output of 135k–155k oz gold and 45–60M lbs copper, but faces rising costs—Q3 AISC jumped to $2,421/oz and full-year AISC guidance was raised to $1,600–$1,675/oz. Market positioning reflects this divergence: ARMN shares have gained ~138% over six months with a forward P/E ~7.37x and a Zacks Rank #1, while EGO is up ~75% with a forward P/E ~8.35x, Zacks Rank #3, and weaker near-term margin dynamics.

Analysis

Market structure: ARMN is the near-term winner — production +36.6% YoY in Q3 and Segovia second mill materially raises throughput while cash of $417.9M funds growth; EGO is the loser in the short run as AISC jumped to $2,421/oz in Q3 versus ARMN’s ~$1,641/oz, pressuring margins and free cash flow. Market share/pricing: ARMN’s expanding Latin American footprint and 6.5M+ oz Toroparu resource shift incremental low-cost supply toward ARMN over 12–36 months, while Skouries (EGO) is a high-capex copper-gold swing asset due mid-2026 that can re-weight EGO exposure to copper prices. Cross-asset: stronger ARMN cash reduces near-term equity dilution and bond issuance risk; EGO’s cost pressure raises equity financing/credit risk and increases downside VEga in options; copper from Skouries (45–60M lb in 2026) can tighten copper curves and boost FX flows in Greece/Turkey corridors.

Risk assessment: Tail risks include Colombian/Guyanese permitting reversals, a failed Marmato Bulk Mining startup (delay >12 months), or Skouries ramp failure at Q1–Q2 2026; each could swing EPS by >50% vs current Zacks estimates. Time horizons: immediate (30–90 days) — Q4/2025 guidance and AISC updates; short-term (3–12 months) — Skouries first/ commercial prod. and Olympias throughput; long-term (12–36 months) — Toroparu feasibility and Soto Norte PFS conversion. Hidden dependency: royalties tied to spot gold magnify cost inflation — a $200/oz gold move can change net margins by $20–40/oz after royalties and taxes. Catalysts: quarterly AISC cadence, Skouries ramp, Toroparu DFS/PFS milestones, and any royalty/tax policy changes in operating jurisdictions.

trade implications: Direct: initiate a modest long position in ARMN (size 2–4% portfolio) to capture operational leverage and development optionality; underweight or hedge EGO (reduce to 0–1% or short 1–2%) given elevated AISC and execution risk. Pair: dollar-neutral long ARMN / short EGO (1:0.6–0.8) to express margin divergence through mid-2026, unwind on Skouries commercial steadiness or ARMN PFS delays beyond 12 months. Options: buy ARMN 9–15 month call spreads or Jan 2027 LEAPs to control downside, and buy 3–6 month OTM puts on EGO (5–10% OTM) to hedge a downside surprise. Entry/exit: scale into ARMN on any pullback ≥10% from current levels; trim if ARMN fwd P/E >10 or AISC >$1,900 for two consecutive quarters; exit EGO short if consolidated AISC returns < $1,700 by Q2 2026.

contrarian angles: Consensus overlooks that rising gold prices increase royalties and can compress margins paradoxically — EGO’s AISC spike already reflects this and could continue if gold stays high. ARMN’s 138% six‑month run may be pricing in ideal execution (P/E 7.37 vs median 4.54); downside from Delays in Toroparu or Marmato could be larger than modeled. Historical parallels: mill commissioning often produces step-change in costs/throughput (30–60 days volatility) before steady-state; mispricing exists where EGO’s lower forward P/E (8.35 vs median 10.61) hides execution risk while ARMN’s premium has lower margin of safety. Unintended consequence: a strong gold market could prompt governments to raise royalties/taxes, reversing apparent winners into losers within 12–24 months.

Key Decisions for Investors

• Establish a 2–4% portfolio long in ARMN (ARMN) sized to risk appetite; scale in on up to a 10% pullback; target +30–40% upside in 12 months and set a stop-loss at -20% or if consolidated AISC > $1,900/oz for two consecutive quarters.
• Implement a dollar‑neutral pair trade: long ARMN (notional $1) / short EGO (notional $0.6–0.8) over 3–12 months to capture margin/AISC divergence; unwind if Skouries achieves stable commercial production by mid‑2026 or ARMN development milestones slip >12 months.
• Buy ARMN 9–15 month call spreads (or Jan‑2027 LEAPs near ATM) equal to ~1% portfolio to leverage upside while capping premium; concurrently purchase 3–6 month 5–10% OTM puts on EGO as a downside hedge sized to 0.5–1% of portfolio.
• Reduce direct EGO equity exposure to 0–1% unless consolidated AISC comes down below $1,700/oz by Q2 2026 or Skouries delivers steady-state production; if AISC remains > $2,000/oz into Q1 2026, increase hedge/short sizing to 1–2%.
• Monitor three hard triggers closely: quarterly consolidated AISC (thresholds $1,700 and $2,000/oz), Skouries commercial production status by mid‑2026, and ARMN cash balance remaining > $350M; adjust positions within 5 trading days of any trigger breach.